Gene · 6304
Papers1,882
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,882
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long noncoding RNA LIRIL2R modulates FOXP3 levels and suppressive function of human CD4+ regulatory T cells by regulating IL2RA. | Proc Natl Acad Sci U S A | 2024 | 38805281 | PubTator, text mining | PubMed |
| SATB1, senescence and senescence-related diseases. | J Cell Physiol | 2024 | 38801120 | PubTator, text mining | PubMed |
| Non-Specific Epileptic Activity, EEG, and Brain Imaging in Loss of Function Variants in SATB1: A New Case Report and Review of the Literature. | Genes (Basel) | 2024 | 38790177 | PubTator, text mining | PubMed |
| The miR-641-STIM1 and SATB1 axes play important roles in the regulation of the Th17/Treg balance in ITP. | Sci Rep | 2024 | 38755179 | PubTator, text mining | PubMed |
| Genetic mechanism regulating diversity in the placement of eyes on the head of animals. | Proc Natl Acad Sci U S A | 2024 | 38588419 | PubTator, text mining | PubMed |
| Hi-C, a chromatin 3D structure technique advancing the functional genomics of immune cells. | Front Genet | 2024 | 38586584 | PubTator, text mining | PubMed |
| Retraction: Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma. | PLoS One | 2024 | 38564511 | PubTator, text mining | PubMed |
| Retraction: SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT. | PLoS One | 2024 | 38564501 | PubTator, text mining | PubMed |
| CRIF1 deficiency induces FOXP3LOW inflammatory non-suppressive regulatory T cells, thereby promoting antitumor immunity. | Sci Adv | 2024 | 38536932 | PubTator, text mining | PubMed |
| CD38-RyR2 axis-mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer. | Proc Natl Acad Sci U S A | 2024 | 38451948 | PubTator, text mining | PubMed |
| Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer. | Transl Oncol | 2024 | 38412660 | PubTator, text mining | PubMed |
| SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression. | Cancer Biol Ther | 2024 | 38385627 | PubTator, text mining | PubMed |
| A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer. | Sci Rep | 2024 | 38332160 | PubTator, text mining | PubMed |
| The SATB1-MIR22-GBA axis mediates glucocerebroside accumulation inducing a cellular senescence-like phenotype in dopaminergic neurons. | Aging Cell | 2024 | 38303548 | PubTator, text mining | PubMed |
| Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets. | Cell Commun Signal | 2024 | 38279122 | PubTator, text mining | PubMed |
| Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR-153-3p/SATB1 signaling pathway. | Thorac Cancer | 2024 | 38268309 | PubTator, text mining | PubMed |
| Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes. | Mol Cancer | 2024 | 38254110 | PubTator, text mining | PubMed |
| Cell-cell communication characteristics in breast cancer metastasis. | Cell Commun Signal | 2024 | 38243240 | PubTator, text mining | PubMed |
| Deciphering the significance of anoikis in bladder cancer and systematic analysis of S100A7 as a potential therapeutic target. | Eur J Med Res | 2024 | 38217031 | PubTator, text mining | PubMed |
| Using multi-scale genomics to associate poorly annotated genes with rare diseases. | Genome Med | 2024 | 38178268 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6304/papers?page=5